May 21, 2020
Healthcare workers to participate in chloroquine study
Editor's Note
An international study will include more than 30,000 front-line healthcare workers to assess whether chloroquine can prevent COVID-19 or decrease its severity.
Washington University School of Medicine in St Louis is the clinical coordinating center for the study.
Healthcare workers will be divided randomly into four groups. Three groups will receive chloroquine at various doses, and the fourth group will receive a placebo.
The study will last 5 months.
Free Daily News
- Kentucky Derby, SPD race: Leadership lessons energized SPD professionals at HSPA 2025
- Continuum-based protocol offers new strategy for preventing PONV after thyroidectomy
- Pembrolizumab sets new standard in advanced head and neck cancer surgery, trial shows
- Subarachnoid spinal anesthesia offers safe, effective option for high-risk obstetric patients
- Same-day discharge after catheter ablation gains backing from top cardiology societies
- Tenet, HCA post strong Q1 results, but caution looms over policy uncertainty, outpatient trends
- Telemedicine transforms postoperative care through safer, faster, patient-centered recovery
- ASCA conference coverage to keep ASC leaders informed
- Study: Prolonged COVID symptoms more likely for healthcare workers
- Study: Patients of female surgeons experience fewer complications, lower long-term readmission
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement